The CONQUER study enrolled 2,487 overweight and obese adults, with participants receiving high-dose Qsymia (15mg phentermine/92mg topiramate) achieving 10.2% weight loss compared to 1.8% with placebo
Finan B, Clemmensen C, Zhu Z et al (2016) Chemical hybridization of glucagon and thyroid hormone optimizes therapeutic impact for metabolic disease
No, this is a digital download
From a treatment perspective, the ups and downs associated with this could end up being hard to manage as, for example, insulin sensitivity may change in response to variation in Glucagon levels
To avoid this, consider switching to non-oral methods like an IUD, patch, or vaginal ring while on therapy
Phantom Driver Analogy (02:00:14) Self & Strivings